POST OPERATIVE INHALED NITRIC OXIDE USE AND EARLY OUTCOMES AFTER FONTAN SURGERY COMPLETION

[1]  T. Ojala,et al.  The effect of sildenafil on pleural and peritoneal effusions after the TCPC operation , 2019, Acta anaesthesiologica Scandinavica.

[2]  Y. Tominaga,et al.  Post-Extubation Inhaled Nitric Oxide Therapy via High-Flow Nasal Cannula After Fontan Procedure , 2019, Pediatric Cardiology.

[3]  J. Alten,et al.  Routine Sildenafil Does Not Improve Clinical Outcomes After Fontan Operation , 2017, Pediatric Cardiology.

[4]  G. Wernovsky,et al.  Risk Factors for Longer Hospital Stay Following the Fontan Operation , 2016, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[5]  Sean M. O'Brien,et al.  The Society of Thoracic Surgeons Congenital Heart Surgery Database Mortality Risk Model: Part 2-Clinical Application. , 2015, The Annals of thoracic surgery.

[6]  W. Wells,et al.  Reduced pleural drainage, length of stay, and readmissions using a modified Fontan management protocol. , 2015, The Journal of thoracic and cardiovascular surgery.

[7]  S. Langley,et al.  A defined management strategy improves early outcomes after the Fontan procedure: the PORTLAND protocol. , 2015, The Annals of thoracic surgery.

[8]  S. Belda,et al.  Pulmonary vasodilator therapy and early postoperative outcome after modified Fontan operation , 2014, Cardiology in the Young.

[9]  R. Ohye,et al.  Vasoactive–inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass* , 2010, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[10]  Jiming Cai,et al.  Nitric oxide and milrinone: combined effect on pulmonary circulation after Fontan-type procedure: a prospective, randomized study. , 2008, The Annals of thoracic surgery.

[11]  S. Bradley.  Extracardiac Conduit Fontan Procedure , 2006 .

[12]  P. D. del Nido,et al.  Incorporation of the hepatic veins into the cavopulmonary circulation in patients with heterotaxy and pulmonary arteriovenous malformations after a Kawashima procedure. , 2005, The Annals of thoracic surgery.

[13]  J. Tweddell,et al.  A medical strategy to reduce persistent chest tube drainage after the fontan operation. , 2005, The American journal of cardiology.

[14]  Jesse D. Roberts,et al.  Inhaled Nitric Oxide A Selective Pulmonary Vasodilator Current Uses and Therapeutic Potential , 2004 .

[15]  Masahiro Yoshida,et al.  Inhaled Nitric Oxide Therapy After Fontan-Type Operations , 2004, Surgery Today.

[16]  J. Deanfield,et al.  Basal Pulmonary Vascular Resistance and Nitric Oxide Responsiveness Late After Fontan-Type Operation , 2003, Circulation.

[17]  C. Ramaciotti,et al.  Fenestration Improves Clinical Outcome of the Fontan Procedure: A Prospective, Randomized Study , 2002, Circulation.

[18]  J. Tweddell,et al.  Factors Related to Pleural Effusions After Fontan Procedure in the Era of Fenestration , 2001, Circulation.

[19]  B. Rigler,et al.  Transcatheter coil occlusion of residual interatrial communications after Fontan procedure , 1998, Heart.

[20]  J. Lock,et al.  Baffle fenestration with subsequent transcatheter closure. Modification of the Fontan operation for patients at increased risk. , 1990, Circulation.

[21]  B. Marino,et al.  Inferior vena cava-pulmonary artery extracardiac conduit. A new form of right heart bypass. , 1990, The Journal of thoracic and cardiovascular surgery.